Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DPEP3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ABCB11 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MORC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CDHR5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DRP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TET1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IDS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
AREG - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GM2A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
HMCES - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SEL1L3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MMP11 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PYGM - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DEFA6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
COL4A5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LMAN1L - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SAP18 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RBBP6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on